Objectives: Clinical data and cost-effectiveness analyses from several countries support the use of low-dose computed tomography (LDCT) to screen patients with high risk of lung cancer (LC). This study aimed to explore the economic value of screening LC with LDCT in Hungary.
Methods: Cohorts of screened and nonscreened subjects were simulated in a decision analytic model over their lifetime.